arrow
M

Mirvat Alasnag

king fahd armed forces hospital
H指数:21
被引数:2,490

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic Value of AI-Based Quantitative Coronary CTA vs Human Reader-Based Visual Assessment

基于人工智能的定量冠状动脉CTA与基于人工读片的视觉评估的预后价值

2025-12-010
OAAI
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis

急性冠状动脉综合征女性患者的抗血栓药物:性别调整治疗和随机临床试验中的女性代表。欧洲经皮心血管介入学会(EAPCI)和欧洲心脏病学会血栓工作组(ESC Working Group on Thrombosis)的临床共识声明

2025-05-200
PRE
Impact of Society Guidelines on Trends in Use of Newer P2Y12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

社会指南对接受经皮冠状动脉介入治疗的急性冠脉综合征患者使用新型P2Y12抑制剂趋势的影响

2024-05-070
OAAI
Impact of the COVID-19 Pandemic on Global TAVR Activity The COVID-TAVI Study

新型冠状病毒肺炎大流行对全球TAVR活动的影响covid-tavi研究

2024-02-013
OAAI
Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk

高出血风险患者按性别进行的简化或标准双重抗血小板治疗

2024-01-0112
OA
Rationale and design of the CONFIRM2 (Quantitative COroNary CT Angiography Evaluation For Evaluation of Clinical Outcomes: An InteRnational, Multicenter Registry) study

CONFIRM2 (用于评估临床结果的定量冠状动脉CT血管造影评估: 一项国际多中心注册研究) 研究的原理和设计

2024-01-014
OAAI